Submitted by Anonymous (not verified) on 21 November 2025 - 14:30
Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 59, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 59, Status: Authorised